Intra-cellular Therapies, Inc.

This study tests an experimental drug, ITI-1284, to see if it can safely reduce agitation in people with Alzheimer's dementia. About 320 participants will receive either the drug or a placebo, with the dose adjusted as needed. The main goal is to measure changes in agitated behav…

This study tests an experimental drug called ITI-1284 in adults with generalized anxiety disorder (GAD) who haven't gotten enough relief from current treatments. About 570 participants will receive either ITI-1284 or a placebo added to their usual therapy. The main goal is to see…

This study tests whether a new drug called ITI-1284 can help adults with generalized anxiety disorder (GAD) whose current treatment isn't working well enough. About 705 participants will receive either ITI-1284 or a placebo added to their usual anxiety medication. The main goal i…

This study tests an experimental drug, ITI-1284, to see if it can safely reduce psychosis symptoms (like delusions and hallucinations) in people with Alzheimer's disease. About 370 participants will receive either the drug or a placebo, and researchers will measure changes in sym…